Global Head of Biostatistics

The Opportunity

As the Global Head of Biostatistics, you will provide strategic leadership and oversight across all Therapeutic Area (TA)-aligned Biostatistics teams, ensuring a cohesive and high-performing Biostatistics function that drives excellence in service of our strategy through study design, data analysis, and insights generation.

You will report to the Global Head, PD Data Sciences & Analytics (PD-DSA), and you will be responsible for shaping the Biostatistics strategy across all therapeutic areas in alignment with broader PD-DSA and company objectives, as well as your organization’s overall performance. Your role will be instrumental in advancing innovative statistical methodologies, fostering collaboration across internal and external stakeholders, and ensuring the highest scientific rigor in all statistical activities.

You will lead a global, high-performing organization of approximately 100‑125 Biostatistics professionals focused on late-stage development. Your direct reports will be a team of five therapeutic area–aligned Biostatistics Leaders. Sitting on the PD-DSA leadership team, you will collaborate with senior leaders in PD-DSA and beyond to influence and contribute to the overall strategy and success of late‑stage development programs at Roche.

• Develop and set a clear PD-DSA strategy and goals that align with Roche’s broader objectives, ensuring that you integrate Roche’s One Pharma strategy, PD goals, and R&D Excellence methods into the strategic direction.
• Embed and drive the adoption of PD-DSA’s strategic imperatives of Data, Digital/AI, and Design (the 3
  
  Ds) across your teams’ workflows, taking ownership of this mindset shift to ensure a seamless integration of these principles into daily operations.
• Act as a role model for your teams by delivering excellence in all aspects of your work (what you do, how you do it, and the impact you have), fostering a culture of learning, growth, and continuous improvement that empowers team members to reach their potential.
• Define and create clear accountability across each function in your organization and beyond, ensuring that you work in lock‑step with your colleagues and partners to maintain alignment and drive cross‑functional collaboration.

• Provide strategic leadership and oversight across all five Therapeutic Area‑aligned Biostatistics leaders and their teams, ensuring a consistent and high‑quality approach to Biostatistics across all therapeutic areas.
• Develop and implement a comprehensive Biostatistics strategy that aligns with Roche’s research and development objectives.
• Ensure that biostatistical considerations are integrated early in study designs and development programs, aligning with regulatory and scientific best practices.
• Partner closely with senior leadership across PD-DSA, clinical development, regulatory affairs, and data science teams to shape the future of statistical contributions within Roche.
• Represent Biostatistics as a strategic function, influencing high‑level decision‑making and driving cross‑functional collaboration to optimize study designs and data strategies.
• Evaluate challenges as they arise and develop innovative solutions for teams to execute.

• Act as the primary liaison between the Biostatistics function and key stakeholders across Clinical, Regulatory, and Data Science teams to drive alignment and shape outcomes for shared objectives; connect key stakeholders with therapeutic area Biostatistics Leaders as nuanced questions arise.
• Ensure seamless collaboration between Biostatistics and external partners, including regulatory agencies, academic institutions, and industry consortia.
• Represent Roche in industry forums, regulatory discussions, and cross‑industry collaborations to influence and stay ahead of emerging biostatistics trends.
• Align closely with the PD‑DSA‑led Innovation Council and broader AI strategy to ensure Biostatistics contributes meaningfully to the company’s digital and AI transformation initiatives.

• Ensure the highest scientific rigor and adherence to regulatory…